Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNF Drug

E-ISSN： 2212-3911|1|3|259-264

ISSN： 1574-8863

Source： Current Drug Safety, Vol.1, Iss.3, 2006-08, pp. : 259-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Self-assessment of 28-joint disease activity scores by patients with rheumatoid arthritis on anti-TNF therapy

By Shaffu Shireen Edwards Jill Neame Rebecca Hassan Waji

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 576-578

Oxford University Press

Access to resources Recommend Favorite

Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis

By Haberhauer Guenther

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 220-224

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of methods for measuring dose escalation of the subcutaneous TNF antagonists for rheumatoid arthritis patients treated in routine clinical practice

By Huang Xingyue Gu Ning Yan Fox Kathleen M. Harrison David J. Globe Denise

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1637-1645

Informa Healthcare

Access to resources Recommend Favorite

Undetectable anti‐TNF drug levels in patients with long‐term remission predict successful drug withdrawal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 356-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications—authors’ reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 448-448

John Wiley & Sons Inc

Access to resources Recommend Favorite